Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Period:
Draw Mode:
| Volume | 3,934,352 |
|
|||||
| News | - | ||||||
| Day High | 10.45 | Low High |
|||||
| Day Low | 10.08 | ||||||
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| Iovance Biotherapeutics Inc | IOVA | NASDAQ | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded
|
|
|---|---|---|---|---|
| 0.11 | 1.07% | 10.35 | 19:27:38 |
| Open Price | Low Price | High Price | Close Price | Prev Close |
|---|---|---|---|---|
| 10.18 | 10.08 | 10.45 | 10.35 | 10.24 |
| Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
|---|---|---|---|---|---|
| 34,381 | 3,934,352 | $ 10.32 | $ 40,584,781 | - | 3.21 - 18.33 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 19:43:43 | 4 | $ 10.40 | USD |
Iovance Biotherapeutics (IOVA) Options Flow Summary
Iovance Biotherapeutics Inc Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| 2.89B | 279.31M | - | 1.19M | -444.04M | -1.59 | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
Iovance Biotherapeutics News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical IOVA Price Data
| Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 11.21 | 11.47 | 10.08 | 10.65 | 6,550,762 | -0.86 | -7.67% |
| 1 Month | 11.54 | 14.23 | 10.08 | 11.75 | 5,397,640 | -1.19 | -10.31% |
| 3 Months | 15.80 | 18.33 | 10.08 | 14.07 | 6,517,444 | -5.45 | -34.49% |
| 6 Months | 5.54 | 18.33 | 5.14 | 11.23 | 8,272,135 | 4.81 | 86.82% |
| 1 Year | 7.44 | 18.33 | 3.21 | 9.05 | 7,258,068 | 2.91 | 39.11% |
| 3 Years | 17.25 | 28.00 | 3.21 | 10.43 | 4,495,972 | -6.90 | -40.00% |
| 5 Years | 15.30 | 54.2081 | 3.21 | 14.26 | 3,348,267 | -4.95 | -32.35% |
Iovance Biotherapeutics Description
| Iovance Biotherapeutics Inc is a clinical-stage biopharmaceutical company. The company focused on the development and commercialization of cell therapies as novel cancer immunotherapy products designed to harness the power of a patient's immune system to eradicate cancer cells. Its lead pipeline candidate, LN-145, is an adoptive cell therapy using tumor-infiltrating lymphocytes to treat patients with refractory metastatic melanoma. |
